(86 days)
Not Found
Not Found
No
The document describes ventilation tubes for the ear and contains no mention of AI or ML technology.
Yes
The device is indicated for chronic or recurrent otitis media, acute otitis media with complications, and Eustachian tube dysfunction, all of which are therapeutic indications to alleviate symptoms or treat conditions.
No
Explanation: The provided text describes "Neozoline Ventilation Tubes" which are used to treat conditions like otitis media and Eustachian tube dysfunction. These are therapeutic devices, not diagnostic ones. Diagnostic devices are used to identify a disease or condition, while therapeutic devices are used to treat or manage a disease or condition.
No
The device description explicitly states "Neozoline Ventilation Tubes," which are physical medical devices (tubes inserted into the ear). There is no mention of software as the primary or sole component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVDs are used to examine specimens from the human body. The description of the Neozoline Ventilation Tubes indicates they are implanted into the ear to treat conditions like otitis media and Eustachian tube dysfunction. This is a therapeutic device, not a diagnostic one that analyzes biological samples.
- The intended use describes a treatment for ear conditions. The indications for use clearly outline the patient populations and conditions for which the ventilation tubes are intended to provide relief or improvement, not to diagnose a condition by analyzing a sample.
Therefore, the Neozoline Ventilation Tubes are a medical device, but not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The largest patient population are children between 4 months and 6 years of age (but not exclusively). Otological ventilation tubes are indicated for patients with:
- Chronic or recurrent otitis media with persistent effusion (OME).
- Recurrent acute otitis media.
- Acute otitis media with complications.
- Eustachian tube dysfunction resulting in one or more of the following: significant and symptomatic hearing loss, otalgia, vertigo, and tinnitus.
- Hearing loss resulting from bilateral chronic middle ear effusion.
Product codes
ETD
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
The largest patient population are children between 4 months and 6 years of age (but not exclusively).
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 874.3880 Tympanostomy tube.
(a)
Identification. A tympanostomy tube is a device that is intended to be implanted for ventilation or drainage of the middle ear. The device is inserted through the tympanic membrane to permit a free exchange of air between the outer ear and middle ear. A type of tympanostomy tube known as the malleous clip tube attaches to the malleous to provide middle ear ventilation. The device is made of materials such as polytetrafluoroethylene, polyethylene, silicon elastomer, or porous polyethylene.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is a stylized image of three human profiles facing right, with flowing lines beneath them.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP - 6 2006
Adept Medical c/o Jason Marsh P.O. Box 10075 Dominion Road Auckland, New Zealand
Re: K061058
Trade/Device Name: Neozoline Ventilation Tubes Regulation Number: 21 CFR 874.3880 Regulation Name: Tympanostomy Tubes Regulatory Class: Class II Product Code: ETD Dated: June 16, 2006 Received June 19, 2006
Dear Mr. Marsh:
This letter corrects our substantially equivalent letter of July 12, 2006.
We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your becamed the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for ass stated in the May 28, 1976, the enactment date of the Medical Device Amendments or to conninered proc to May 20, 1978, the oncordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may. and Cosmette free the device, subject to the general controls provisions of the Act. The general therefore, manter the act include requirements for annual registration, listing of devices, controls provisions of the receiners, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA). if your device is classified (600 above). Existing major regulations affecting your device can be it may be subject to additions, Title 21, Parts 800 to 898. In addition, FDA may round in the Coule of Poucharts concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not nean I Trase of advised that I Dris Issualites or our device complies with other requirements of the Act that I DA has made a determination administered by other Federal agencies. You must of any redital statures and regulations daminders but not limited to: registration and listing (21 Compry with an the Act 3 requirements, news, as and acturing practice requirements as set Of It in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic form in the quality brovisions (sections 531-542 of the Act); 21 CFR 1000-1050.
1
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html.
Sincerely yours,
M.B. Egelman, M.D.
Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
K061058 510(k) Number (if known):
Neozoline Ventilation Tubes Device Name:
Indications For Use:
The largest patient population are children between 4 months and 6 years of age (but not exclusively). Otological ventilation tubes are indicated for patients with:
- Chronic or recurrent otitis media with persistent effusion (OME). ।
- Recurrent acute otitis media. -
- Acute otitis media with complications. -
- Eustachian tube dysfunction resulting in one or more of the following: significant and symptomatic hearing loss, otalgia, vertigo, and tinnitus.
- Hearing loss resulting from bilateral chronic middle ear effusion. -
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Klaus Barker
Division Sign-C of Ophthalmic Ear,
510(k) Number K060508
Page 1 of 1 __